Profile picture

Associate Professor Dirk von Lewinski

Medical University of Graz, Graz (Austria)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

Hemodynamic balance in acute and advanced heart failure: intra-venous vaso-active options - The Acute Heart Failure settings: role of hemodynamic active drugs, differential effects of drug families
Session
Hemodynamic balance in acute and advanced heart failure: intra-venous vaso-active options - The Acute Heart Failure settings: role of hemodynamic active drugs, differential effects of drug families
27 May 2019
Hemodynamic balance in acute and advanced heart failure: intra-venous vaso-active options - The Acute Heart Failure settings: role of hemodynamic active drugs, differential effects of drug families
Session
Hemodynamic balance in acute and advanced heart failure: intra-venous vaso-active options - The Acute Heart Failure settings: role of hemodynamic active drugs, differential effects of drug families
26 May 2019
Inotropes in acute heart failure: from guidelines to practical use - Therapeutic options and clinical practice
Session
Inotropes in acute heart failure: from guidelines to practical use - Therapeutic options and clinical practice
28 August 2018
Inotropes in acute heart failure: from guidelines to practical use - Therapeutic options and clinical practice
Session
Inotropes in acute heart failure: from guidelines to practical use - Therapeutic options and clinical practice
27 August 2018
Inotropes in acute heart failure - From guidelines to practical use
Session
Inotropes in acute heart failure - From guidelines to practical use
28 May 2018
Inotropes in acute heart failure - From guidelines to practical use
Session
Inotropes in acute heart failure - From guidelines to practical use
27 May 2018
Inotropes or inodilators in heart failure with reduced ejection fraction: what to use, when and how? - What is available? Pros and cons of inodilators. In which patient?
Session
Inotropes or inodilators in heart failure with reduced ejection fraction: what to use, when and how? - What is available? Pros and cons of inodilators. In which patient?
29 August 2017
Inotropes or inodilators in heart failure with reduced ejection fraction (HFrEF): what to use, when and how? What is available? Pros and cons of inodilators. In which patient?
Session
Inotropes or inodilators in heart failure with reduced ejection fraction (HFrEF): what to use, when and how? What is available? Pros and cons of inodilators. In which patient?
27 August 2017

ESC 365 is supported by